Molecular Diagnostics
Rapid Virus Test Delivers Lab Quality Results within 30 Minutes
Researchers have developed a rapid test for viruses that can deliver results as accurate as lab tests within 30 minutes. The technology can be applied to viruses that cause respiratory syncytial virus, influenza and COVID-19. More...26 Apr 2022
Blood Test Identifies Those at High Risk of Developing Human Tuberculosis
New research presented at ECCMID 2022 has shown that Actiphage, a new blood test for Mycobacterium tuberculosis (Mtb) can improve identification of those at risk of progressive tuberculosis infection, offering potential for a rapid, non-invasive biomarker for early screening of asymptomatic individuals. More...26 Apr 2022
RNA-Based Noninvasive Gut Tests Enable Early Colorectal Cancer Screening
A new diagnostic platform uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. Unlike other noninvasive screening options that use DNA or blood-based biomarkers, the proprietary method from Geneoscopy Inc. (St. Louis, MO, USA) analyzes RNA extracted from patient stool samples to provide the phenotypic and quantitative information necessary to accurately detect precancerous lesions. More...25 Apr 2022
New BD Assay Speeds Discovery in Autoimmune Disorders, Immuno-Oncology, and Infectious Diseases
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has launched the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases. More...22 Apr 2022
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Alcohol Testing Device
Dräger Alcotest 7000
In Other News
Testing for Protein in Blood Receives More Support as Biomarker for Brain Disorders
Blood Test to Diagnose Skin Cancer May Help Avoid Invasive Skin Biopsies
Tumor Suppressor Adenomatous Polyposis Coli Regulates T Lymphocyte Migration
A Novel Small RNA Biomarker for Early Liver Cancer Diagnosis
NGS Technology-Based Assay Detects Minimal Residual Disease in Patients with Lymphatic Hematological Tumors
World’s First Rapid Oral Cancer Test to Revolutionize Diagnosis and Treatment
Broad Gene Panel Diagnoses Patients With Kidney Disease
Single-Cell RNA-Seq Reveals Cell Type–Specific Molecular and Genetic Associations to Lupus
Lyo-Ready PCR Reagents Make Ultra-Sensitive Diagnostics Development Painless
Smartphone-Powered Microfluidic ‘Lab on a Strip’ Dengue Test More Powerful Than LFT Testing
Single-Cell RNA Sequencing Identifies Mechanisms Underlying Autoimmune Diseases
Cervicovaginal DNA Virome Alterations Associated with Genital Inflammation
High-Throughput Screening Assay Identifies Drugs to Treat Resistant Prostate Cancer
Circulating Levels of Anti-Müllerian Hormone Can Identify Premenopausal Women Prior to Significant Bone Density Loss
POC Sepsis Diagnostic Platform to Speed up Clinical and Treatment Decision Making
AI-Powered Voice-Activated Pipettes Streamline Processes and Increase Lab Productivity
Liquid Biopsy Enables Early Cancer Detection in Li-Fraumeni Syndrome Patients
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
Blood Test to Detect Protein Biomarkers Identified Using Breast Milk Could Enable Breast Cancer Screening
Newly Identified Biomarkers Detect Subcortical Small-vessel Disease
miRNA-Based Blood Borne Diagnostic Test Holds Potential for Management of Cancer Patients
Liquid Biopsy Can Detect Recurrent Breast Cancer and Monitor Progression
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.